Evaluation of gastrointestinal oppotunistic infections in patients using steroids

Evaluation of gastrointestinal oppotunistic infections in patients using steroids - Evaluation of gastrointestinal opportunistic infections in patients using steroids

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002868

Enrollment

150

Registered

2009-12-10

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients using steroids

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with adminstration of steroids internally or intravenously at more than 2weeks

Exclusion criteria

Exclusion criteria: Patients with history of gastric rection Patients with HIV and HTLV-1 infection Patients with Primary Immunodeficiency Syndrome Patients with severe liver and renal disfancction In cases when previous information of gastrointestinal lesion is known Patients with anti-CMV medication and antibacterial drug with 4 weeks

Design outcomes

Primary

Measure	Time frame
Clinical data on types, consumption, Period of steroid use, underlying disease, symptoms, and usage history of immunosuppressants among the presence of gastrointestinal opportunistic infections (candidasis, Cytomegalovirus, mycobacteria)	—

Secondary

Measure	Time frame
Endosocpic findings of gastrointestinal opportunistic infections	—

Countries

Japan

Contacts

Public ContactNaoyoshi Nagata

International Medical Center of Japan Gastroenterology

gastriccarcinoma@yahoo.co.jp03-3202-7181

Outcome results